INR 97.91
(2.59%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 767.77 Million INR | 45.85% |
2022 | 336.09 Million INR | 270.7% |
2021 | 90.66 Million INR | 27.19% |
2020 | 71.28 Million INR | 13714.53% |
2019 | 516 Thousand INR | -99.67% |
2018 | 154.4 Million INR | 110.73% |
2017 | 73.27 Million INR | 315.28% |
2016 | 17.64 Million INR | -92.92% |
2015 | 249.11 Million INR | 347.94% |
2014 | 55.61 Million INR | -84.46% |
2013 | 357.97 Million INR | 414.6% |
2012 | 69.56 Million INR | -96.4% |
2011 | 1.93 Billion INR | 2454.52% |
2010 | -82.1 Million INR | -105.59% |
2009 | 1.46 Billion INR | 59.6% |
2008 | 920.7 Million INR | -37.57% |
2007 | 1.47 Billion INR | 26.19% |
2006 | 1.16 Billion INR | 26.8% |
2005 | 921.62 Million INR | 35.89% |
2004 | 678.22 Million INR | 2.21% |
2003 | 663.57 Million INR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 179 Million INR | 18.97% |
2023 Q1 | 90.5 Million INR | 185.49% |
2023 FY | 490.2 Million INR | 45.85% |
2023 Q2 | 561.6 Million INR | 520.55% |
2023 Q3 | 112.5 Million INR | -79.97% |
2023 Q4 | 226.7 Million INR | 101.51% |
2022 Q4 | 31.7 Million INR | -71.67% |
2022 Q1 | 37.5 Million INR | 145.66% |
2022 Q2 | 684.5 Million INR | 1725.33% |
2022 Q3 | 111.9 Million INR | -83.65% |
2022 FY | 336.09 Million INR | 270.7% |
2021 FY | 90.66 Million INR | 27.19% |
2021 Q4 | 15.26 Million INR | -38.2% |
2021 Q3 | 24.7 Million INR | 51.53% |
2021 Q2 | 16.3 Million INR | -44.75% |
2021 Q1 | 29.5 Million INR | -45.73% |
2020 Q2 | 15.1 Million INR | 894.74% |
2020 Q3 | 28.8 Million INR | 90.73% |
2020 FY | 71.28 Million INR | 13714.53% |
2020 Q4 | 54.35 Million INR | 88.74% |
2020 Q1 | -1.9 Million INR | 86.52% |
2019 Q3 | -10.7 Million INR | -154.87% |
2019 Q2 | 19.5 Million INR | 170.83% |
2019 Q4 | -14.09 Million INR | -31.74% |
2019 FY | 516 Thousand INR | -99.67% |
2019 Q1 | 7.2 Million INR | 333.16% |
2018 Q3 | 23.6 Million INR | -59.24% |
2018 Q2 | 57.9 Million INR | -23.82% |
2018 Q1 | 76 Million INR | 1388.14% |
2018 FY | 154.4 Million INR | 110.73% |
2018 Q4 | -3.08 Million INR | -113.08% |
2017 FY | 73.27 Million INR | 315.28% |
2017 Q4 | -5.9 Million INR | 0.0% |
2016 Q4 | 32.6 Million INR | 0.0% |
2016 FY | 17.64 Million INR | -92.92% |
2015 Q3 | -33.5 Million INR | -137.64% |
2015 Q2 | 89 Million INR | 178.13% |
2015 Q1 | 32 Million INR | 123.56% |
2015 FY | 249.11 Million INR | 347.94% |
2015 Q4 | -17.7 Million INR | 47.16% |
2014 FY | 55.61 Million INR | -84.46% |
2014 Q2 | 28.2 Million INR | -34.72% |
2014 Q3 | -29.7 Million INR | -205.32% |
2014 Q4 | 14.31 Million INR | 148.2% |
2014 Q1 | 43.2 Million INR | -73.83% |
2013 Q1 | 86.4 Million INR | 64.37% |
2013 Q4 | 165.07 Million INR | 534.9% |
2013 Q3 | 26 Million INR | -67.7% |
2013 Q2 | 80.5 Million INR | -6.83% |
2013 FY | 357.97 Million INR | 414.6% |
2012 Q3 | 115.6 Million INR | 279.5% |
2012 Q4 | 52.56 Million INR | -54.53% |
2012 FY | 69.56 Million INR | -96.4% |
2012 Q1 | -34.1 Million INR | -101.68% |
2012 Q2 | -64.4 Million INR | -88.86% |
2011 Q3 | -32.4 Million INR | 0.0% |
2011 FY | 1.93 Billion INR | 2454.52% |
2011 Q4 | 2.02 Billion INR | 6358.44% |
2010 FY | -82.1 Million INR | -105.59% |
2009 FY | 1.46 Billion INR | 59.6% |
2008 Q4 | 56.5 Million INR | 0.0% |
2008 FY | 920.7 Million INR | -37.57% |
2007 FY | 1.47 Billion INR | 26.19% |
2006 FY | 1.16 Billion INR | 26.8% |
2005 FY | 921.62 Million INR | 35.89% |
2004 FY | 678.22 Million INR | 2.21% |
2003 FY | 663.57 Million INR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 5.75 Billion INR | 86.666% |
Hester Biosciences Limited | 364.77 Million INR | -110.481% |
Aarti Drugs Limited | 7.14 Billion INR | 89.26% |
Aarti Pharmalabs Limited | 3.12 Billion INR | 75.456% |
Albert David Limited | 1.33 Billion INR | 42.466% |
Alkem Laboratories Limited | 19.46 Billion INR | 96.055% |
Bafna Pharmaceuticals Limited | 237.66 Million INR | -223.053% |
Bajaj HealthCare Limited | - INR | -Infinity% |
Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -3616.935% |
Brooks Laboratories Limited | -72.25 Million INR | 1162.628% |
Eris Lifesciences Limited | 5.18 Billion INR | 85.183% |
FDC Limited | 3.03 Billion INR | 74.692% |
Glenmark Life Sciences Limited | 8.97 Billion INR | 91.449% |
Gufic Biosciences Limited | 2.89 Billion INR | 73.468% |
Hikal Limited | 1.49 Billion INR | 48.617% |
Ind-Swift Limited | 1.22 Billion INR | 37.374% |
Innova Captab Limited | 2.53 Billion INR | 69.694% |
IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | 84.465% |
Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -258.704% |
Jubilant Pharmova Limited | 5.18 Billion INR | 85.204% |
Lincoln Pharmaceuticals Limited | 1.9 Billion INR | 59.725% |
Lupin Limited | 27.75 Billion INR | 97.234% |
Mangalam Drugs & Organics Limited | 27.45 Million INR | -2696.161% |
Medico Remedies Limited | 277.11 Million INR | -177.055% |
Morepen Laboratories Limited | 4.17 Billion INR | 81.605% |
Nectar Lifesciences Limited | 3.89 Billion INR | 80.266% |
Orchid Pharma Limited | 2.36 Billion INR | 67.482% |
Procter & Gamble Health Limited | 2.78 Billion INR | 72.442% |
RPG Life Sciences Limited | 2.29 Billion INR | 66.507% |
Kilitch Drugs (India) Limited | 208.05 Million INR | -269.031% |
Sigachi Industries Limited | 1.47 Billion INR | 47.909% |
Solara Active Pharma Sciences Limited | -3.85 Billion INR | 119.927% |
Suven Pharmaceuticals Limited | 4.6 Billion INR | 83.337% |
Themis Medicare Limited | 1.3 Billion INR | 41.081% |
Unichem Laboratories Limited | - INR | -Infinity% |
Vaishali Pharma Limited | 6.29 Million INR | -12098.443% |
Wanbury Limited | 1.7 Billion INR | 55.028% |
Windlas Biotech Limited | 1.29 Billion INR | 40.89% |
ZIM Laboratories Limited | 1.09 Billion INR | 30.083% |
Ind-Swift Laboratories Limited | 2 Billion INR | 61.784% |
Ipca Laboratories Limited | 29.59 Billion INR | 97.406% |
Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 99.264% |
Venus Remedies Limited | 534.65 Million INR | -43.602% |
Sakar Healthcare Limited | 495.5 Million INR | -54.947% |
Aurobindo Pharma Limited | 104.5 Billion INR | 99.265% |
Divi's Laboratories Limited | 18.31 Billion INR | 95.807% |
AstraZeneca Pharma India Limited | 4.47 Billion INR | 82.839% |
Mankind Pharma Limited | 40.86 Billion INR | 98.121% |
Sequent Scientific Limited | - INR | -Infinity% |
Laurus Labs Limited | 3.94 Billion INR | 80.556% |
Neuland Laboratories Limited | 5.31 Billion INR | 85.563% |
J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 89.82% |
Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 88.192% |
Zydus Lifesciences Limited | 45.39 Billion INR | 98.309% |
Amrutanjan Health Care Limited | 621.02 Million INR | -23.629% |
Wockhardt Limited | 140 Million INR | -448.407% |
Bal Pharma Limited | 214.56 Million INR | -257.82% |
Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 98.866% |
Bliss GVS Pharma Limited | 1.23 Billion INR | 37.63% |
Par Drugs and Chemicals Limited | 551.58 Million INR | -39.192% |
Caplin Point Laboratories Limited | 7.22 Billion INR | 89.374% |
Shilpa Medicare Limited | 3.76 Billion INR | 79.589% |
Valiant Laboratories Limited | - INR | -Infinity% |
Ajanta Pharma Limited | 19.67 Billion INR | 96.098% |
Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -27021.766% |
Granules India Limited | 6.52 Billion INR | 88.239% |
Medicamen Biotech Limited | - INR | -Infinity% |
Syncom Formulations (India) Limited | 249.25 Million INR | -208.031% |
Piramal Enterprises Limited | - INR | -Infinity% |
Torrent Pharmaceuticals Limited | 25.33 Billion INR | 96.97% |
NATCO Pharma Limited | 25.96 Billion INR | 97.043% |
Suven Life Sciences Limited | -1.22 Billion INR | 162.633% |
Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
Strides Pharma Science Limited | 5.22 Billion INR | 85.308% |
Indoco Remedies Limited | 1.52 Billion INR | 49.635% |
Alpa Laboratories Limited | 61.51 Million INR | -1148.102% |
Lasa Supergenerics Limited | -458 Million INR | 267.634% |
Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 118.658% |